Preveceutical Medical Stock Performance
| PRVCF Stock | USD 0.02 0.0004 2.37% |
PreveCeutical Medical holds a performance score of 7 on a scale of zero to a hundred. The company holds a Beta of -9.09, which implies a somewhat significant risk relative to the market. As returns on the market increase, returns on owning PreveCeutical Medical are expected to decrease by larger amounts. On the other hand, during market turmoil, PreveCeutical Medical is expected to outperform it. Use PreveCeutical Medical jensen alpha, semi variance, price action indicator, as well as the relationship between the maximum drawdown and daily balance of power , to analyze future returns on PreveCeutical Medical.
Risk-Adjusted Performance
Fair
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in PreveCeutical Medical are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile fundamental indicators, PreveCeutical Medical reported solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 156.4 K | |
| Total Cashflows From Investing Activities | -52.7 K |
PreveCeutical |
PreveCeutical Medical Relative Risk vs. Return Landscape
If you would invest 4.12 in PreveCeutical Medical on October 29, 2025 and sell it today you would lose (2.39) from holding PreveCeutical Medical or give up 58.01% of portfolio value over 90 days. PreveCeutical Medical is currently producing 5.8072% returns and takes up 58.8532% volatility of returns over 90 trading days. Put another way, most equities are less risky on the basis of their return distribution than PreveCeutical, and majority of traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
PreveCeutical Medical Target Price Odds to finish over Current Price
The tendency of PreveCeutical OTC Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 0.02 | 90 days | 0.02 | about 57.12 |
Based on a normal probability distribution, the odds of PreveCeutical Medical to move above the current price in 90 days from now is about 57.12 (This PreveCeutical Medical probability density function shows the probability of PreveCeutical OTC Stock to fall within a particular range of prices over 90 days) .
Assuming the 90 days horizon PreveCeutical Medical has a beta of -9.09 indicating as returns on its benchmark rise, returns on holding PreveCeutical Medical are expected to decrease by similarly larger amounts. On the other hand, during market turmoils, PreveCeutical Medical is expected to outperform its benchmark. In addition to that PreveCeutical Medical has an alpha of 7.2478, implying that it can generate a 7.25 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). PreveCeutical Medical Price Density |
| Price |
Predictive Modules for PreveCeutical Medical
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as PreveCeutical Medical. Regardless of method or technology, however, to accurately forecast the otc stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the otc stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of PreveCeutical Medical's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
PreveCeutical Medical Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. PreveCeutical Medical is not an exception. The market had few large corrections towards the PreveCeutical Medical's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold PreveCeutical Medical, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of PreveCeutical Medical within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 7.25 | |
β | Beta against Dow Jones | -9.09 | |
σ | Overall volatility | 0.01 | |
Ir | Information ratio | 0.11 |
PreveCeutical Medical Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of PreveCeutical Medical for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for PreveCeutical Medical can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| PreveCeutical Medical is way too risky over 90 days horizon | |
| PreveCeutical Medical has some characteristics of a very speculative penny stock | |
| PreveCeutical Medical appears to be risky and price may revert if volatility continues | |
| PreveCeutical Medical has high likelihood to experience some financial distress in the next 2 years | |
| PreveCeutical Medical has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations | |
| PreveCeutical Medical has accumulated 1.68 M in total debt with debt to equity ratio (D/E) of 347.6, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. PreveCeutical Medical has a current ratio of 0.02, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist PreveCeutical Medical until it has trouble settling it off, either with new capital or with free cash flow. So, PreveCeutical Medical's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like PreveCeutical Medical sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for PreveCeutical to invest in growth at high rates of return. When we think about PreveCeutical Medical's use of debt, we should always consider it together with cash and equity. | |
| Net Loss for the year was (1.73 M) with profit before overhead, payroll, taxes, and interest of 2.25 K. | |
| PreveCeutical Medical has accumulated about 2.64 K in cash with (426.39 K) of positive cash flow from operations. | |
| Roughly 24.0% of PreveCeutical Medical outstanding shares are owned by corporate insiders |
PreveCeutical Medical Fundamentals Growth
PreveCeutical OTC Stock prices reflect investors' perceptions of the future prospects and financial health of PreveCeutical Medical, and PreveCeutical Medical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on PreveCeutical OTC Stock performance.
| Return On Asset | -3.31 | |||
| Current Valuation | 12.06 M | |||
| Shares Outstanding | 523.3 M | |||
| Price To Sales | 3,902 X | |||
| EBITDA | (1.28 M) | |||
| Cash And Equivalents | 2.64 K | |||
| Total Debt | 1.68 M | |||
| Debt To Equity | 347.60 % | |||
| Book Value Per Share | (0.01) X | |||
| Cash Flow From Operations | (426.39 K) | |||
| Earnings Per Share | (0) X | |||
| Total Asset | 161.2 K | |||
About PreveCeutical Medical Performance
By analyzing PreveCeutical Medical's fundamental ratios, stakeholders can gain valuable insights into PreveCeutical Medical's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if PreveCeutical Medical has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if PreveCeutical Medical has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
PreveCeutical Medical Inc., a health sciences company, engages in the development of options for preventive and curative therapies utilizing organic and nature identical products. PreveCeutical Medical Inc. is headquartered in Vancouver, Canada. Preveceutical Medical operates under Biotechnology classification in the United States and is traded on OTC Exchange.Things to note about PreveCeutical Medical performance evaluation
Checking the ongoing alerts about PreveCeutical Medical for important developments is a great way to find new opportunities for your next move. OTC Stock alerts and notifications screener for PreveCeutical Medical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| PreveCeutical Medical is way too risky over 90 days horizon | |
| PreveCeutical Medical has some characteristics of a very speculative penny stock | |
| PreveCeutical Medical appears to be risky and price may revert if volatility continues | |
| PreveCeutical Medical has high likelihood to experience some financial distress in the next 2 years | |
| PreveCeutical Medical has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations | |
| PreveCeutical Medical has accumulated 1.68 M in total debt with debt to equity ratio (D/E) of 347.6, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. PreveCeutical Medical has a current ratio of 0.02, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist PreveCeutical Medical until it has trouble settling it off, either with new capital or with free cash flow. So, PreveCeutical Medical's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like PreveCeutical Medical sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for PreveCeutical to invest in growth at high rates of return. When we think about PreveCeutical Medical's use of debt, we should always consider it together with cash and equity. | |
| Net Loss for the year was (1.73 M) with profit before overhead, payroll, taxes, and interest of 2.25 K. | |
| PreveCeutical Medical has accumulated about 2.64 K in cash with (426.39 K) of positive cash flow from operations. | |
| Roughly 24.0% of PreveCeutical Medical outstanding shares are owned by corporate insiders |
- Analyzing PreveCeutical Medical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether PreveCeutical Medical's stock is overvalued or undervalued compared to its peers.
- Examining PreveCeutical Medical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating PreveCeutical Medical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of PreveCeutical Medical's management team can help you assess the OTC Stock's leadership.
- Pay attention to analyst opinions and ratings of PreveCeutical Medical's otc stock. These opinions can provide insight into PreveCeutical Medical's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for PreveCeutical OTC Stock analysis
When running PreveCeutical Medical's price analysis, check to measure PreveCeutical Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PreveCeutical Medical is operating at the current time. Most of PreveCeutical Medical's value examination focuses on studying past and present price action to predict the probability of PreveCeutical Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PreveCeutical Medical's price. Additionally, you may evaluate how the addition of PreveCeutical Medical to your portfolios can decrease your overall portfolio volatility.
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |